TGA provisionally approves Pfizer COVID-19 vaccine
The TGA has granted provisional approval to Pfizer Australia Pty Ltd for its COVID-19 vaccine, COMIRNATY, making it the first COVID-19 vaccine to receive regulatory approval in Australia.
Published
Related content
- TGA provisionally approves AstraZeneca's COVID-19 vaccineThe TGA has granted provisional approval to AstraZeneca Pty Ltd for its COVID-19 vaccine
- Pfizer's COVID-19 vaccine (COMIRNATY) provisionally approved for use as a booster in individuals aged 16-17 years oldThe TGA has provisionally approved the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for use as a booster in individuals aged 16 and 17 years old.
- Pfizer's COVID-19 vaccine (COMIRNATY) provisionally approved for use in individuals 5 years and overThe TGA has provisionally approved the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for use in individuals 5 years and older.